Status:
COMPLETED
Markers and Mechanisms of Vascular Disease in Type II Diabetes
Lead Sponsor:
US Department of Veterans Affairs
Collaborating Sponsors:
American Diabetes Association
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
40+ years
Brief Summary
OBJECTIVES: Vascular Disease is the leading cause of complications and death in patients with diabetes. Risk markers and underlying mechanisms have not been fully elucidated, and may differ from those...
Detailed Description
Primary Hypothesis: Secondary Hypotheses: Primary Outcomes: Study Abstract: OBJECTIVES: Vascular Disease is the leading cause of complications and death in patients with diabetes. Risk markers and...
Eligibility Criteria
Inclusion
- Patients with type 2 DM who are no longer responsive to maximum dose of one or more oral agents
Exclusion
- Patients that did not participate in the VADT.
Key Trial Info
Start Date :
June 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
298 Patients enrolled
Trial Details
Trial ID
NCT00256646
Start Date
June 1 2007
End Date
May 1 2008
Last Update
May 23 2014
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Carl T. Hayden VA Medical Center
Phoenix, Arizona, United States, 85012
2
Southern Arizona VA Health Care System, Tucson
Tucson, Arizona, United States, 85723
3
VA Central California Health Care System, Fresno
Fresno, California, United States, 93703
4
VA Medical Center, Long Beach
Long Beach, California, United States, 90822